The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

Iowa Secretary of Ag Weighs In on The H5N1 Battle, Vaccine Potential And Trade Sensitivities Sec. Mike Naig says the U.S. government is using what he describes as a three-legged stool approach to ...

Trump Administration Shifts Strategy on Avian Flu Spearheaded by National Economic Council Director Kevin Hassett and USDA Secretary Brooke Rollins, the plan prioritizes enhanced biosecurity ...